IN158328B
(es)
*
|
1981-03-09 |
1986-10-18 |
Ici Plc |
|
JPS5839618A
(ja)
*
|
1981-09-04 |
1983-03-08 |
Chugai Pharmaceut Co Ltd |
持続性積層錠剤
|
JPS58152813A
(ja)
*
|
1982-03-08 |
1983-09-10 |
Sumitomo Chem Co Ltd |
鮮明な刻印を有する錠剤およびその製法
|
DK152744C
(da)
*
|
1982-08-13 |
1988-10-31 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
|
DK151608C
(da)
*
|
1982-08-13 |
1988-06-20 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
|
US4503031A
(en)
*
|
1982-12-17 |
1985-03-05 |
Glassman Jacob A |
Super-fast-starting-sustained release tablet
|
DE3314003A1
(de)
*
|
1983-04-18 |
1984-10-18 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
|
US4591500A
(en)
*
|
1983-04-25 |
1986-05-27 |
Microencapsulation S.A. |
Tablet having the shape of a capsule, process and device for its preparation
|
JPS604120A
(ja)
*
|
1983-06-22 |
1985-01-10 |
Shionogi & Co Ltd |
作用持続型ピナシジル製剤
|
DE3505433A1
(de)
*
|
1985-02-16 |
1986-08-21 |
Basf Ag, 6700 Ludwigshafen |
Direkttablettierhilfsmittel
|
US4631305A
(en)
*
|
1985-03-22 |
1986-12-23 |
The Upjohn Company |
Polymeric material as a disintegrant in a compressed tablet
|
DE3869337D1
(de)
*
|
1987-11-20 |
1992-04-23 |
Greither Peter |
Kapsel und verfahren zu ihrer herstellung.
|
US5051261A
(en)
*
|
1987-11-24 |
1991-09-24 |
Fmc Corporation |
Method for preparing a solid sustained release form of a functionally active composition
|
KR940000280Y1
(ko)
*
|
1987-12-17 |
1994-01-19 |
디 엎죤 캄파니 |
3중 스코어(score)를 가진 약 정제
|
DE69014513T2
(de)
*
|
1989-09-21 |
1995-05-24 |
American Cyanamid Co |
System des Typs "einmal täglich" zur gepulsten Minocyclinabgabe.
|
EP0418596A3
(en)
*
|
1989-09-21 |
1991-10-23 |
American Cyanamid Company |
Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
|
US5009896A
(en)
*
|
1989-10-04 |
1991-04-23 |
Akzo N.V. |
Multi-fractionable tablet structure
|
US5213738A
(en)
*
|
1990-05-15 |
1993-05-25 |
L. Perrigo Company |
Method for making a capsule-shaped tablet
|
US5061494A
(en)
*
|
1990-06-14 |
1991-10-29 |
The Upjohn Comany |
Tri-scored drug tablet
|
DE4100920A1
(de)
*
|
1991-01-15 |
1992-07-16 |
Degussa |
Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
|
GB9101502D0
(en)
*
|
1991-01-23 |
1991-03-06 |
Controlled Therapeutics Sct |
Controlled release compositions
|
US5262173A
(en)
*
|
1992-03-02 |
1993-11-16 |
American Cyanamid Company |
Pulsatile once-a-day delivery systems for minocycline
|
US5398851A
(en)
*
|
1993-08-06 |
1995-03-21 |
River Medical, Inc. |
Liquid delivery device
|
US5571261A
(en)
*
|
1993-08-06 |
1996-11-05 |
River Medical, Inc |
Liquid delivery device
|
US5398850A
(en)
*
|
1993-08-06 |
1995-03-21 |
River Medical, Inc. |
Gas delivery apparatus for infusion
|
FR2709420B1
(fr)
*
|
1993-09-01 |
1995-11-17 |
Sogeval |
Comprimé vétérinaire plus spécialement destiné aux chats.
|
US6129930A
(en)
*
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US5700245A
(en)
*
|
1995-07-13 |
1997-12-23 |
Winfield Medical |
Apparatus for the generation of gas pressure for controlled fluid delivery
|
US5756124A
(en)
*
|
1995-08-07 |
1998-05-26 |
Invamed, Inc. |
Multi-scored pharmaceutical tablets
|
GB9613470D0
(en)
|
1996-06-27 |
1996-08-28 |
Ciba Geigy Ag |
Small solid oral dosage form
|
GB9624563D0
(en)
*
|
1996-11-27 |
1997-01-15 |
Smithkline Beecham Plc |
Product
|
DE69938268T2
(de)
*
|
1998-04-03 |
2009-04-30 |
Kyowa Hakko Kogyo Co., Ltd. |
Teilbare Tablette und Durchdrückpackung
|
US6602521B1
(en)
*
|
1998-09-29 |
2003-08-05 |
Impax Pharmaceuticals, Inc. |
Multiplex drug delivery system suitable for oral administration
|
DE19856147A1
(de)
|
1998-12-04 |
2000-06-08 |
Knoll Ag |
Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
|
GB9914620D0
(en)
*
|
1999-06-23 |
1999-08-25 |
Eu Pharma Ltd |
Divisible tablets
|
WO2001000176A1
(en)
*
|
1999-06-23 |
2001-01-04 |
Eu Pharma Ltd. |
Divisible tablets
|
SE0100200D0
(sv)
*
|
2001-01-24 |
2001-01-24 |
Astrazeneca Ab |
New film coating
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
TW200502000A
(en)
*
|
2003-03-28 |
2005-01-16 |
Kyowa Hakko Kogyo Kk |
Dividing tablet
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
US20060270658A1
(en)
|
2003-09-03 |
2006-11-30 |
Donald Manning |
Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
|
FR2859632B1
(fr)
*
|
2003-09-15 |
2005-11-18 |
Arrow Generiques |
Comprime multisecable a observance amelioree.
|
DE202004002700U1
(de)
*
|
2004-02-20 |
2004-04-29 |
Desitin Arzneimittel Gmbh |
Viertelbare Tablette
|
CN1993111A
(zh)
*
|
2004-05-21 |
2007-07-04 |
阿库-伯雷克技术公司 |
含有相对无活性片段的药片
|
US7838031B2
(en)
*
|
2004-05-21 |
2010-11-23 |
Lawrence Solomon |
Method of administering a partial dose using a segmented pharmaceutical tablet
|
CA2565029C
(en)
*
|
2004-05-21 |
2013-09-03 |
Lawrence Solomon |
Immediate release pharmaceutical tablets with height greater than width
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
GB0423964D0
(en)
*
|
2004-10-28 |
2004-12-01 |
Jagotec Ag |
Dosage form
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
EP1712224A1
(en)
*
|
2005-04-12 |
2006-10-18 |
Alexander von Mérey |
Divisible rectangular flat tablet
|
AU2006308448A1
(en)
|
2005-09-09 |
2007-05-03 |
Labopharm (Barbados) Limited |
Sustained drug release composition
|
TWI274889B
(en)
*
|
2005-10-06 |
2007-03-01 |
Elan Microelectronics Corp |
Resistive touch screen measurement system
|
US20070160960A1
(en)
*
|
2005-10-21 |
2007-07-12 |
Laser Shot, Inc. |
System and method for calculating a projectile impact coordinates
|
US7985419B1
(en)
|
2006-12-22 |
2011-07-26 |
Watson Laboratories, Inc. |
Divisible tablet and associated methods
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US20080311162A1
(en)
*
|
2007-05-16 |
2008-12-18 |
Olivia Darmuzey |
Solid form
|
US20080286343A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Dzenana Cengic |
Solid form
|
US20080286344A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Olivia Darmuzey |
Solid form
|
WO2008140461A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
WO2008140460A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
WO2008140459A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
CN102014877B
(zh)
|
2008-01-25 |
2017-06-06 |
格吕伦塔尔有限公司 |
药物剂型
|
FR2928836B1
(fr)
*
|
2008-03-21 |
2011-08-26 |
Servier Lab |
Forme galenique secable permettant une liberation modifiee du principe actif
|
LT2273983T
(lt)
|
2008-05-09 |
2016-10-25 |
Grünenthal GmbH |
Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
|
TW201006473A
(en)
*
|
2008-08-13 |
2010-02-16 |
Orient Pharma Co Ltd |
Bi-layer medicine tablet containing Zaleplon
|
US20100104687A1
(en)
*
|
2008-10-24 |
2010-04-29 |
Kaplan Allan S |
Segmented confectionery products
|
CN102573806B
(zh)
|
2009-07-22 |
2015-02-25 |
格吕伦塔尔有限公司 |
用于对氧化敏感的阿片类物质的抗破坏剂型
|
AU2010275753B2
(en)
|
2009-07-22 |
2014-08-21 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
WO2011095314A2
(en)
|
2010-02-03 |
2011-08-11 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
ES2487244T3
(es)
|
2010-09-02 |
2014-08-20 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación que comprende un polímero aniónico
|
AU2011297901B2
(en)
|
2010-09-02 |
2014-07-31 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
JO3283B1
(ar)
|
2011-04-26 |
2018-09-16 |
Sanofi Sa |
تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
|
PT2736495T
(pt)
|
2011-07-29 |
2017-11-30 |
Gruenenthal Gmbh |
Comprimido resistente à adulteração proporcionando libertação imediata de fármaco
|
CN103857386A
(zh)
|
2011-07-29 |
2014-06-11 |
格吕伦塔尔有限公司 |
提供药物立即释放的抗破碎片剂
|
CA2864949A1
(en)
|
2012-02-28 |
2013-09-06 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
WO2013156453A1
(en)
|
2012-04-18 |
2013-10-24 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
US20140141078A1
(en)
*
|
2012-09-15 |
2014-05-22 |
Jeffery K. Slaboden |
Dissolvable TableT
|
BR112015029616A2
(pt)
|
2013-05-29 |
2017-07-25 |
Gruenenthal Gmbh |
forma de dosagem resistente à adulteração com perfil de liberação bimodal
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
CA2917136C
(en)
|
2013-07-12 |
2022-05-31 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
WO2015078891A1
(en)
|
2013-11-26 |
2015-06-04 |
Farmaceutici Formenti S.P.A. |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
MX2016014738A
(es)
|
2014-05-12 |
2017-03-06 |
Gruenenthal Gmbh |
Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
|
EA201692388A1
(ru)
|
2014-05-26 |
2017-05-31 |
Грюненталь Гмбх |
Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
|
HUE043951T2
(hu)
|
2014-07-18 |
2019-09-30 |
Sanofi Sa |
Eljárás rákgyanús beteg aflibercepttel történõ kezelése kimenetének elõrejelzésére
|
EA035434B1
(ru)
|
2015-04-24 |
2020-06-15 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
|
WO2017042325A1
(en)
|
2015-09-10 |
2017-03-16 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
USD805726S1
(en)
*
|
2016-03-11 |
2017-12-26 |
Mars, Incorporated |
Pet food
|
USD909825S1
(en)
|
2018-08-22 |
2021-02-09 |
Land O'lakes, Inc. |
Die
|
USD909148S1
(en)
|
2018-08-22 |
2021-02-02 |
Land O'lakes, Inc. |
Die
|
USD869116S1
(en)
|
2018-08-22 |
2019-12-10 |
Land O'lakes, Inc. |
Butter stick
|
USD869117S1
(en)
|
2018-08-22 |
2019-12-10 |
Land O'lakes, Inc. |
Butter stick
|
USD871016S1
(en)
*
|
2019-05-10 |
2019-12-31 |
Land O'lakes, Inc. |
Butter stick
|
USD918526S1
(en)
|
2019-11-12 |
2021-05-11 |
Land O'lakes, Inc. |
Butter stick
|
WO2021185804A1
(en)
|
2020-03-16 |
2021-09-23 |
Grünenthal GmbH |
Scored tablet
|
US20210378968A1
(en)
*
|
2020-05-28 |
2021-12-09 |
Johnson & Johnson Consumer Inc. |
Multi-cavity customizable dosage forms
|